3rd Quarter - Amendment

WILLIAMS AND JENSEN, PLLC for NOVARTIS INC

Firm
Client
Income
$80,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 18, 2013 $60,000 Replaced
3rd Quarter - Amendment (this page) Mar 4, 2014 $80,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Drug safety and drug counterfeiting (track and trace); Drug importation; Authorized generics; Drug company patent settlements; Prescription drug advertising; Federal preemption for prescription drugs; implementation of the Patient Protection and Affordable Care Act;and drug shortages.

LobbyistCovered position, as disclosed
MICHAEL BEER New LA, Rep. Dave Hobson
JENNY DIJAMES New LA and LD, Rep. Bud Cramer
JACK STEVEN HART New —
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA —
KARINA LYNCH —
MELINDA M MAXFIELD —
ERIN BOOK MULLEN —
GEORGE OLSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Medicare prescription drug benefit; Rebates for Medicare Part D; Independent Payment Advisory Board (IPAB). House and Senate Budget resolutions. Tax Application of the ACA section 9008 to orphan drugs.

LobbyistCovered position, as disclosed
JENNY DIJAMES —
SUSAN HIRSCHMANN —
KARINA LYNCH —
GEORGE OLSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Funding for pandemic influenza countermeasures.

LobbyistCovered position, as disclosed
MATTHEW B HOEKSTRA —
GEORGE OLSEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.